Dianthus Therapeutics Banner

SEC Filing Details

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results

Document Details

Filing Date
Mar 31, 2023
Document Date
Mar 31, 2023
Form Description
Registration of certain classes of securities 12(b) of the Securities Exchange Act
Filing Group
Registration Statements
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/